New Delhi: One of the questions doing the rounds on the COVID-19 vaccination process in India was whether citizens could choose their vaccine from the ones approved by Drugs Controller ...
Bhubaneswar: The Health Ministry on Tuesday announced that there will be no option for the 3 crore frontline workers to choose which of the two vaccines to take. The first phase ...
Bhubaneswar: Indigenously developed Covaxin COVID-19 vaccine by Bharat Biotech is likely to be priced lower than Serum Institute's Covishield. Covishield will be sold at Rs 200 per vial to the ...
New Delhi: The impending danger of the new mutant strain of coronavirus found in the UK helped Bharat Biotech get emergency use approval for its vaccine candidate Covaxin. India has ...
New Delhi: Bharat Biotech-developed vaccine candidate COVAXIN will be affective on mutant strains of the novel coronavirus, the company expressed confidence at a press conference on Monday. According to Bharat ...
Surat: With the Congress raising doubts over the efficacy of COVID-19 vaccine, Union Minister Dharmendra Pradhan termed people with such mentality as 'mandh buddhi'. The Union Minister said those doubting ...
Bhubaneswar: After the announcement on kicking off the COVID-19 vaccination drive by this month-end, the Health and Family Welfare department on Monday ordered identification of session sites. A five-member team ...
Bhubaneswar: Health Minister Naba Das on Monday said the COVID-19 vaccine is likely to reach Odisha by January 30. Das said as per protocol COVID warriors, including frontline health workers ...
New Delhi: The Drugs Controller General of India (DCGI) has approved Bharat Biotech's Covaxin for children above the age of 12 years while Oxford-AstraZeneca's vaccine Covishield, manufactured by Pune-based Serum ...
New Delhi: The All India Drug Action Network (AIDAN) has urged the Drugs Controller General of India (DCGI) to reconsider the recommendations of the SEC in granting the REU approval ...